IRON
Disc Medicine, Inc.
NASDAQ · USHealthcareBiotechnology
$74.38-2.32%
Price as of Jul 20, 2026
IRON growth
Disc Medicine, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- —
- EBITDA
- —
- EBIT
- -92.2%
- EPS
- -69.4%
- Free cash flow
- -95.5%
- Operating cash flow
- -97.9%
Forward estimates
- Revenue
- —
- EBITDA
- —
- EPS
- -11.2%
Three-year CAGR
- Revenue
- —
- EBITDA
- -92.0%
- EBIT
- -81.9%
- Net income
- -94.0%
- EPS
- -51.8%
- Free cash flow
- -92.0%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.